Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.48 |
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | PAM | P19021 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | HTR2A | P28223 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL95143 | 1.00 | SIGMAR1 (0.48) | SIGMAR1IDO1PAMMAOBHTR2A | |
| SCHEMBL1532665 | 0.89 | IDO1 (0.44) | SIGMAR1IDO1PAMMAOBHTR2A | |
| SCHEMBL96607 | 0.86 | SIGMAR1 (0.46) | SIGMAR1IDO1PAMMAOBHTR2A | |
| SCHEMBL96606 | 0.86 | SIGMAR1 (0.46) | SIGMAR1IDO1PAMMAOBHTR2A | |
| SCHEMBL7939387 | 0.85 | IDO1 (0.56) | SIGMAR1IDO1PAMMAOBHTR2A | |
| SCHEMBL7568412 | 0.85 | IDO1 (0.56) | SIGMAR1IDO1PAMMAOBHTR2A | |
| SCHEMBL10430031 | 0.85 | IDO1 (0.56) | SIGMAR1IDO1PAMMAOBHTR2A | |
| SCHEMBL21178175 | 0.85 | SIGMAR1 (0.44) | SIGMAR1IDO1PAMMAOBHTR2A | |
| SCHEMBL1003495 | 0.83 | SIGMAR1 (0.43) | SIGMAR1IDO1PAMMAOBHTR2A | |
| SCHEMBL542493 | 0.83 | SIGMAR1 (0.43) | SIGMAR1IDO1PAMMAOBHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118308007-A | Ocean antifouling paint with piezoelectric conductivity and preparation and application thereof | 武汉理工大学三亚科教创新园 | 2024-07-09 | — | — | CN | claimed |
| CN-118185421-A | Piezoelectric semiconductor composite coating based on silicon dioxide, preparation method and application | 武汉理工大学 | 2024-06-14 | — | — | CN | claimed |
| CN-116161896-A | Antistatic sound absorbing material, preparation method thereof, loudspeaker and electronic equipment | 镇江贝斯特新材料股份有限公司 | 2023-05-26 | — | — | CN | claimed |
| CN-112280245-A | Resin composition, prepreg, metal-clad laminate, and circuit board | 苏州生益科技有限公司 | 2021-01-29 | — | — | CN | claimed |
| CN-108004789-B | A kind of preparation method of electrochromism liquid crystal microcapsule used for textiles | 江南大学 | 2019-06-07 | — | — | CN | claimed |
| CN-108004789-A | A kind of preparation method of electrochromism liquid crystal microcapsule used for textiles | 江南大学 | 2018-05-08 | — | — | CN | claimed |
| EP-0205834-B1 | 7-THIABICYCLOHEPTANE SUBSTITUTED ETHERS | E.R. Squibb & Sons, Inc. (US) | 1990-10-31 | — | — | EP | claimed |
| CN-118222209-A | Black optical film, cured film and application thereof | 杭州福斯特电子材料有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118185421-A | Piezoelectric semiconductor composite coating based on silicon dioxide, preparation method and application | 武汉理工大学 | 2024-06-14 | — | — | CN | disclosed |
| US-11273168-B2 | Methods of treating anxiety by administering a substituted quinolone | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2022-03-15 | — | — | US | disclosed |
| US-11254832-B2 | Fluid sets | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-02-22 | — | — | US | disclosed |
| CN-112280245-A | Resin composition, prepreg, metal-clad laminate, and circuit board | 苏州生益科技有限公司 | 2021-01-29 | — | — | CN | disclosed |
| US-20200308436-A1 | FLUID SETS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2020-10-01 | — | — | US | disclosed |
| US-4845100-A | WITH HYPOTENSIVE AND ANTIINFLAMMATORY ACTIVITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-07-04 | — | — | US | disclosed |
| CN-1030415-A | Saturated heterocycle carboxamide derivatives and its preparation method | YAMANOUCHI PHARMA CO LTD (JP) | 1989-01-18 | — | — | CN | disclosed |
| EP-0279681-A2 | Saturated heterocyclic carboxamide derivatives | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-24 | — | — | EP | disclosed |
| EP-0255134-A2 | Carbostyril derivatives and salts thereof, process for preparing them, and cardiotonic composition containing same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-02-03 | — | — | EP | disclosed |
| EP-0202760-A2 | Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-11-26 | — | — | EP | disclosed |
| EP-0180897-A2 | 5-Fluorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-14 | — | — | EP | disclosed |
| EP-0180188-A2 | A composition for increasing the anti-cancer activity of an anti-cancer compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11273168-B2 | Methods of treating anxiety by administering a substituted quinolone | CRH, MC2R, HTR3C | SIGMAR1 310/4885IDO1 747/4885PAM 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.